Can Targeting Xbp1 mRNA be a Therapeutic Strategy?
Given its central role in the UPR and its involvement in various diseases, targeting Xbp1 mRNA or its regulatory mechanisms presents a promising therapeutic strategy. Small molecules or RNA-based therapies that modulate Xbp1 splicing or function could potentially alleviate ER stress and improve cellular homeostasis in disease contexts.
